73 related articles for article (PubMed ID: 15033468)
1. DNA microarray analysis of the correlation between gene expression patterns and acquired resistance to 5-FU/cisplatin in gastric cancer.
Kim HK; Choi IJ; Kim HS; Kim JH; Kim E; Park IS; Chun JH; Kim IH; Kim IJ; Kang HC; Park JH; Bae JM; Lee JS; Park JG
Biochem Biophys Res Commun; 2004 Apr; 316(3):781-9. PubMed ID: 15033468
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiles in prostate cancer: association with patient subgroups and tumour differentiation.
Halvorsen OJ; Oyan AM; Bø TH; Olsen S; Rostad K; Haukaas SA; Bakke AM; Marzolf B; Dimitrov K; Stordrange L; Lin B; Jonassen I; Hood L; Akslen LA; Kalland KH
Int J Oncol; 2005 Feb; 26(2):329-36. PubMed ID: 15645116
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel genes associated with the response to 5-FU treatment in gastric cancer cell lines using a cDNA microarray.
Park JS; Young Yoon S; Kim JM; Yeom YI; Kim YS; Kim NS
Cancer Lett; 2004 Oct; 214(1):19-33. PubMed ID: 15331170
[TBL] [Abstract][Full Text] [Related]
4. Upregulated expression of S100A6 in human gastric cancer.
Yang YQ; Zhang LJ; Dong H; Jiang CL; Zhu ZG; Wu JX; Wu YL; Han JS; Xiao HS; Gao HJ; Zhang QH
J Dig Dis; 2007 Nov; 8(4):186-93. PubMed ID: 17970874
[TBL] [Abstract][Full Text] [Related]
5. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.
Akervall J; Guo X; Qian CN; Schoumans J; Leeser B; Kort E; Cole A; Resau J; Bradford C; Carey T; Wennerberg J; Anderson H; Tennvall J; Teh BT
Clin Cancer Res; 2004 Dec; 10(24):8204-13. PubMed ID: 15623595
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer.
Tsukamoto Y; Uchida T; Karnan S; Noguchi T; Nguyen LT; Tanigawa M; Takeuchi I; Matsuura K; Hijiya N; Nakada C; Kishida T; Kawahara K; Ito H; Murakami K; Fujioka T; Seto M; Moriyama M
J Pathol; 2008 Dec; 216(4):471-82. PubMed ID: 18798223
[TBL] [Abstract][Full Text] [Related]
7. Correlation between thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level and in vitro chemosensitivity to 5-fluorouracil, in relation to differentiation in gastric cancer.
Fakhrejahani E; Miyamoto A; Tanigawa N
Cancer Chemother Pharmacol; 2007 Aug; 60(3):437-46. PubMed ID: 17377791
[TBL] [Abstract][Full Text] [Related]
8. Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols.
De Angelis PM; Kravik KL; Tunheim SH; Haug T; Reichelt WH
Mol Cancer; 2004 Apr; 3():11. PubMed ID: 15109396
[TBL] [Abstract][Full Text] [Related]
9. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
[TBL] [Abstract][Full Text] [Related]
10. Tumor quantification of several fluoropyrimidines resistance gene expression with a unique quantitative RT-PCR method. Implications for pretherapeutic determination of tumor resistance phenotype.
Barbado M; Preisser L; Boisdron-Celle M; Verriele V; Lorimier G; Gamelin E; Morel A
Cancer Lett; 2006 Oct; 242(2):168-79. PubMed ID: 16387426
[TBL] [Abstract][Full Text] [Related]
11. Gene expression analysis using human cancer xenografts to identify novel predictive marker genes for the efficacy of 5-fluorouracil-based drugs.
Ooyama A; Takechi T; Toda E; Nagase H; Okayama Y; Kitazato K; Sugimoto Y; Oka T; Fukushima M
Cancer Sci; 2006 Jun; 97(6):510-22. PubMed ID: 16734730
[TBL] [Abstract][Full Text] [Related]
12. [Study on gene expression profile difference in gastric cancer, pericancerous mucosa and normal gastric mucosa from the distant cutting margin by oligonucleotide microarray].
Yu CD; Xu SH; Mou HZ; Jiang ZM; Zhu CH; Liu XL
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Nov; 8(6):520-3. PubMed ID: 16299656
[TBL] [Abstract][Full Text] [Related]
13. Expression microarray analysis reveals genes associated with in vitro resistance to cisplatin in a cell line model.
Watson MB; Lind MJ; Smith L; Drew PJ; Cawkwell L
Acta Oncol; 2007; 46(5):651-8. PubMed ID: 17562441
[TBL] [Abstract][Full Text] [Related]
14. Prediction of chemosensitivity using multigene analysis in head and neck squamous cell carcinoma.
Hasegawa Y; Goto M; Hanai N; Ijichi K; Terada A; Hyodo I; Ogawa T; Fukushima M
Oncology; 2007; 73(1-2):104-11. PubMed ID: 18337622
[TBL] [Abstract][Full Text] [Related]
15. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
De Angelis PM; Svendsrud DH; Kravik KL; Stokke T
Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241
[TBL] [Abstract][Full Text] [Related]
16. Determination of genes related to gastrointestinal tract origin cancer cells using a cDNA microarray.
Kim TM; Jeong HJ; Seo MY; Kim SC; Cho G; Park CH; Kim TS; Park KH; Chung HC; Rha SY
Clin Cancer Res; 2005 Jan; 11(1):79-86. PubMed ID: 15671531
[TBL] [Abstract][Full Text] [Related]
17. Prediction of response to neoadjuvant chemotherapy for osteosarcoma by gene-expression profiles.
Ochi K; Daigo Y; Katagiri T; Nagayama S; Tsunoda T; Myoui A; Naka N; Araki N; Kudawara I; Ieguchi M; Toyama Y; Toguchida J; Yoshikawa H; Nakamura Y
Int J Oncol; 2004 Mar; 24(3):647-55. PubMed ID: 14767549
[TBL] [Abstract][Full Text] [Related]
18. Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker.
Huddleston HG; Wong KK; Welch WR; Berkowitz RS; Mok SC
Gynecol Oncol; 2005 Jan; 96(1):77-83. PubMed ID: 15589584
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of malignant and benign gastric biopsy specimens by mRNA expression profile and multivariate statistical methods.
Galamb O; Sipos F; Molnar B; Szoke D; Spisak S; Tulassay Z
Cytometry B Clin Cytom; 2007 Sep; 72(5):299-309. PubMed ID: 17366642
[TBL] [Abstract][Full Text] [Related]
20. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
